Literature DB >> 20945059

[Pyrosequencing in uro-oncology: applications in prostate cancer].

T C Stadler1, A Jung, B Schlenker, P Nuhn, J Ellinger, T Kirchner, C G Stief, P J Bastian.   

Abstract

Changes in the methylation pattern in particular gene promoters as well as genetic sequence mutations play an important role in carcinogenesis. Molecular methods like pyrosequencing provide the specific analysis of these epigenetic and genetic modifications. In this review the relevance of these alterations for prostate cancer and the function of pyrosequencing will be described and explained on the basis of a search of the PubMed literature database. At present, in uro-oncology only a few studies outlining methylation in prostate cancer and pyrosequencing have been published. Nevertheless, it becomes evident that epigenetic mechanisms as well as specific gene sequence alterations have an impact on the carcinogenesis of prostate cancer and knowledge of these factors might open perspectives in diagnostic approaches of the future.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20945059     DOI: 10.1007/s00120-010-2426-1

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  35 in total

1.  Direct analysis of single-nucleotide polymorphism on double-stranded DNA by pyrosequencing.

Authors:  T Nordström; M Ronaghi; L Forsberg; U de Faire; R Morgenstern; P Nyrén
Journal:  Biotechnol Appl Biochem       Date:  2000-04       Impact factor: 2.431

2.  Association of DNA repair and steroid metabolism gene polymorphisms with clinical late toxicity in patients treated with conformal radiotherapy for prostate cancer.

Authors:  Sambasivarao Damaraju; David Murray; Jennifer Dufour; Diana Carandang; Sten Myrehaug; Gino Fallone; Colin Field; Russell Greiner; John Hanson; Carol E Cass; Matthew Parliament
Journal:  Clin Cancer Res       Date:  2006-04-15       Impact factor: 12.531

3.  Association of hereditary prostate cancer gene polymorphic variants with sporadic aggressive prostate carcinoma.

Authors:  Ferrin C Noonan-Wheeler; William Wu; Kimberly A Roehl; Aleksandra Klim; John Haugen; Brian K Suarez; Adam S Kibel
Journal:  Prostate       Date:  2006-01-01       Impact factor: 4.104

4.  Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma.

Authors:  C Jerónimo; H Usadel; R Henrique; J Oliveira; C Lopes; W G Nelson; D Sidransky
Journal:  J Natl Cancer Inst       Date:  2001-11-21       Impact factor: 13.506

Review 5.  Eukaryotic cytosine methyltransferases.

Authors:  Mary Grace Goll; Timothy H Bestor
Journal:  Annu Rev Biochem       Date:  2005       Impact factor: 23.643

6.  Quantification of CpG methylation at the 5'-region of XIST by pyrosequencing from human serum.

Authors:  Min-Ae Song; Jung-Hoon Park; Kyoung-Sin Jeong; Dong Soo Park; Myung Seo Kang; Suman Lee
Journal:  Electrophoresis       Date:  2007-07       Impact factor: 3.535

7.  Association between polymorphisms in cell cycle genes and advanced prostate carcinoma.

Authors:  Adam S Kibel; Carol H Jin; Aleksandra Klim; Jason Luly; Kimberly A Roehl; William S Wu; Brian K Suarez
Journal:  Prostate       Date:  2008-08-01       Impact factor: 4.104

8.  Methylation-specific PCR.

Authors:  J G Herman; S B Baylin
Journal:  Curr Protoc Hum Genet       Date:  2001-05

9.  Age-related DNA methylation changes in normal human prostate tissues.

Authors:  Bernard Kwabi-Addo; Woonbok Chung; Lanlan Shen; Michael Ittmann; Thomas Wheeler; Jaroslav Jelinek; Jean-Pierre J Issa
Journal:  Clin Cancer Res       Date:  2007-07-01       Impact factor: 12.531

10.  Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling.

Authors:  Woonbok Chung; Bernard Kwabi-Addo; Michael Ittmann; Jaroslav Jelinek; Lanlan Shen; Yinhua Yu; Jean-Pierre J Issa
Journal:  PLoS One       Date:  2008-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.